A clinically feasible multiplex proteomic immunoassay as a novel functional diagnostic for pancreatic ductal adenocarcinoma

Authors

Kian-Huat Lim, Washington University School of Medicine in St. Louis
Feng Gao, Washington University School of Medicine in St. Louis
Jingqin Luo, Washington University School of Medicine in St. Louis
Lin Li, Washington University School of Medicine in St. Louis
Vladamir M. Kushnir, Washington University School of Medicine in St. Louis
Dayna S. Early, Washington University School of Medicine in St. Louis
Daniel K. Mullady, Washington University School of Medicine in St. Louis
Dengfeng Cao, Washington University School of Medicine in St. Louis
Riad R. Azar, Washington University School of Medicine in St. Louis
Andrea Wang-Gillam, Washington University School of Medicine in St. Louis
et al

Journal

Oncotarget

Publication Date

2017

Volume

8

Issue

15

Inclusive Pages

24250-24261

Document Type

Open Access Publication

DOI

10.18632/oncotarget.15653

Rights and Permissions

Lim, K. -., Langley, E., Gao, F., Luo, J., Li, L., Meyer, G., . . . Wang-Gillam, A. (2017). A clinically feasible multiplex proteomic immunoassay as a novel functional diagnostic for pancreatic ductal adenocarcinoma. Oncotarget, 8(15), 24250-24261. doi:10.18632/oncotarget.15653. Copyright: Lim et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Recommended Citation

Lim, Kian-Huat; Gao, Feng; Luo, Jingqin; Li, Lin; Kushnir, Vladamir M.; Early, Dayna S.; Mullady, Daniel K.; Cao, Dengfeng; Azar, Riad R.; Wang-Gillam, Andrea; and et al, "A clinically feasible multiplex proteomic immunoassay as a novel functional diagnostic for pancreatic ductal adenocarcinoma." Oncotarget. 8, 15. 24250-24261. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/5796